These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24715602)

  • 1. Cost and cost effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial.
    Pizzi LT; Seligman NS; Baxter JK; Jutkowitz E; Berghella V
    Pharmacoeconomics; 2014 May; 32(5):467-78. PubMed ID: 24715602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis.
    Eddama O; Petrou S; Regier D; Norrie J; MacLennan G; Mackenzie F; Norman JE
    Int J Technol Assess Health Care; 2010 Apr; 26(2):141-8. PubMed ID: 20392316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last.
    Romero R
    Womens Health (Lond); 2011 Sep; 7(5):501-4. PubMed ID: 21879816
    [No Abstract]   [Full Text] [Related]  

  • 5. Revisiting the cost-effectiveness of universal cervical length screening: importance of progesterone efficacy.
    Jain S; Kilgore M; Edwards RK; Owen J
    Am J Obstet Gynecol; 2016 Jul; 215(1):101.e1-7. PubMed ID: 26821336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA; O'Brien JM; Adair CD; Lewis DF; Hall DR; Fusey S; Soma-Pillay P; Porter K; How H; Schakis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth.
    Hoang T; Zierden H; Date A; Ortiz J; Gumber S; Anders N; He P; Segars J; Hanes J; Mahendroo M; Ensign LM
    J Control Release; 2019 Feb; 295():74-86. PubMed ID: 30597245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
    O'Brien JM; Adair CD; Lewis DF; Hall DR; Defranco EA; Fusey S; Soma-Pillay P; Porter K; How H; Schackis R; Eller D; Trivedi Y; Vanburen G; Khandelwal M; Trofatter K; Vidyadhari D; Vijayaraghavan J; Weeks J; Dattel B; Newton E; Chazotte C; Valenzuela G; Calda P; Bsharat M; Creasy GW
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):687-96. PubMed ID: 17899572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of transvaginal ultrasound cervical length screening in singletons without a prior preterm birth: an update.
    Werner EF; Hamel MS; Orzechowski K; Berghella V; Thung SF
    Am J Obstet Gynecol; 2015 Oct; 213(4):554.e1-6. PubMed ID: 26071914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options and recommendations to reduce preterm births in women with short cervix.
    Slager J; Lynne S
    J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial.
    van Os MA; van der Ven AJ; Kleinrouweler CE; Schuit E; Kazemier BM; Verhoeven CJ; de Miranda E; van Wassenaer-Leemhuis AG; Sikkema JM; Woiski MD; Bossuyt PM; Pajkrt E; de Groot CJ; Mol BW; Haak MC
    Am J Perinatol; 2015 Aug; 32(10):993-1000. PubMed ID: 25738790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study.
    Price JT; Phiri WM; Freeman BL; Vwalika B; Winston J; Mabula-Bwalya CM; Mulenga HB; Stringer JSA
    PLoS One; 2020; 15(1):e0224874. PubMed ID: 31995557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ; Nguyen LK; Pham TD; He YTN; Vu KN; Phan MTN; Le TQ; Le CH; Vuong LN; Mol BW
    Obstet Gynecol; 2019 Mar; 133(3):459-467. PubMed ID: 30741812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis.
    Cahill AG; Odibo AO; Caughey AB; Stamilio DM; Hassan SS; Macones GA; Romero R
    Am J Obstet Gynecol; 2010 Jun; 202(6):548.e1-8. PubMed ID: 20079888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study.
    Price JT; Mabula-Bwalya CM; Freeman BL; Carda-Auten J; Phiri WM; Chibwe K; Kantumoya P; Vwalika B; Stringer JSA; Golin CE
    PLoS One; 2020; 15(9):e0238748. PubMed ID: 32970697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012024. PubMed ID: 29086920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
    Cheung KW; Seto MTY; Ng EHY
    Trials; 2020 Jan; 21(1):121. PubMed ID: 32000820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.